101 related articles for article (PubMed ID: 3029010)
1. Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.
Michel-Briand Y; Uccelli V; Laporte JM; Plesiat P
J Antimicrob Chemother; 1986 Dec; 18(6):667-74. PubMed ID: 3029010
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
Uccelli V; Laporte JM; Michel-Briand Y
C R Seances Soc Biol Fil; 1985; 179(5):696-9. PubMed ID: 2938699
[TBL] [Abstract][Full Text] [Related]
3. [Elimination of various virulence plasmids by antibiotics].
Michel-Briand Y; Laporte JM; Dupont MJ; Couetdic G
Pathol Biol (Paris); 1988 Feb; 36(2):159-62. PubMed ID: 3279385
[TBL] [Abstract][Full Text] [Related]
4. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
5. [The role of 4-quinolones and antibiotics in the elimination of virulence plasmids of Enterobacteriaceae].
Michel-Briand Y; Laporte JM; Plesiat P; Sansonetti PJ
Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1386-8. PubMed ID: 3325901
[TBL] [Abstract][Full Text] [Related]
6. Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics.
Michel-Briand Y; Laporte JM; Couetdic G; Sansonetti PJ
Ann Inst Pasteur Microbiol; 1986; 137B(3):291-5. PubMed ID: 3318870
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
Barry AL; Jones RN
Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
[TBL] [Abstract][Full Text] [Related]
8. Elimination of antibiotic-resistant plasmids by quinolone antibiotics.
Fu KP; Grace ME; Hsiao CL; Hung PP
Chemotherapy; 1988; 34(5):415-8. PubMed ID: 3141117
[TBL] [Abstract][Full Text] [Related]
9. Elimination of plasmids by new 4-quinolones.
Weisser J; Wiedemann B
Antimicrob Agents Chemother; 1985 Nov; 28(5):700-2. PubMed ID: 3911881
[TBL] [Abstract][Full Text] [Related]
10. Quinolones in vitro.
Willems FT
Pharm Weekbl Sci; 1986 Feb; 8(1):26-8. PubMed ID: 3960690
[TBL] [Abstract][Full Text] [Related]
11. Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.
Hooper DC; Wolfson JS; McHugh GL; Swartz MD; Tung C; Swartz MN
Antimicrob Agents Chemother; 1984 May; 25(5):586-90. PubMed ID: 6329090
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
13. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
Tabary X; Moreau N; Dureuil C; Le Goffic F
Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
[TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Cantet P; Renaudin H; Quentin C; Bebear C
Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
Thabaut A; Durosoir JL
Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
[TBL] [Abstract][Full Text] [Related]
16. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
17. Plasmid "curing" by some recently synthetized 4-quinolone compounds.
Selan L; Scazzocchio F; Oliva B; Schippa S; Allocati N; Renzini G
Chemioterapia; 1988 Oct; 7(5):292-4. PubMed ID: 3066515
[TBL] [Abstract][Full Text] [Related]
18. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
